|
Q4 FY2025
As of Dec 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
|
|---|---|---|---|---|
| ASSETS | ||||
| Current assets: | ||||
| Cash and cash equivalents | ||||
| Investment in equity securities, at fair value | ||||
| Short term investments | ||||
| Accounts receivable, net of nil expected credit loss | ||||
| Receivable from a related party | ||||
| Inventories | ||||
| Prepaid expenses and other | ||||
| Total current assets | ||||
| Long-term investments | ||||
| Property, plant and equipment, net | ||||
| Intangible assets, net | ||||
| Right of use assets | ||||
| Other assets | ||||
| Total assets | ||||
| LIABILITIES AND SHAREHOLDERS' (DEFICIT) EQUITY | ||||
| Current liabilities: | ||||
| Accounts payable | ||||
| Bank borrowings | ||||
| Accrued and other current liabilities | ||||
| Convertible notes due to a related party | ||||
| Current portion of long term borrowing | ||||
| Total current liabilities | ||||
| Long term borrowing | ||||
| Other liabilities | ||||
| Total liabilities | ||||
| Shareholders' (deficit) equity: | ||||
| $0.0001 par value, 500,000,000 shares authorized 20,967,869 shares and 15,904,533 shares issued at December 31, 2025 and 2024, respectively; 20,555,873 shares and 15,492,581 shares outstanding at December 31, 2025 and 2024, respectively | ||||
| Treasury shares, at cost: 411,996 shares and 411,952 shares held at December 31, 2025 and 2024 | ||||
| Additional paid-in capital | ||||
| Accumulated other comprehensive loss | ||||
| Accumulated deficit | ||||
| Total shareholders' (deficit) equity | ||||
| Total liabilities and shareholders' (deficit) equity | ||||
Loading...
